An expected power approach for the assessment of composite endpoints and their components

Author

G. Rauch and M. Kieser

Computational Statistics & Data Analysis, 2013, vol. 60, issue C, pages 111-122

Abstract: Composite endpoints are increasingly used in clinical trials, particularly in the field of cardiology. Thereby, the overall impact of the therapeutic intervention is captured by including several events of interest in a single variable. To demonstrate the significance of an overall clinical benefit, it is sufficient to assess the test problem for the composite. However, even if a statistically significant and clinically relevant superiority is shown for the composite endpoint, there is the need to evaluate the treatment effects for the components as, for example, a strong effect in one endpoint can mask an adverse effect in another. In most clinical applications, a descriptive analysis of the individual components is performed. However, the question remains what conclusion should be drawn from a trial where the composite shows a significant effect, but some component results which are not based on confirmatory evidence point in an adverse direction. Therefore, the first aim is to define an adequate multiple test problem of the composite and its most important components. Thereby, it might suffice to show superiority with respect to the composite and non-inferiority for the components to guarantee the clinical relevance of the result, as a slightly negative effect in one component might be acceptable as long as the total effect of all components is highly positive. To calculate the power for this multiple test problem, a number of strong assumptions on the effect sizes for the composite and its components as well as on the correlations between them are required. However, knowledge on these quantities is usually very limited and thus the choice of fixed parameter assumptions is based on a low level of evidence. The second aim therefore is to provide a more flexible power definition which takes the uncertainty about parameter assumptions into account. An expected power approach is proposed using prior distributions for the involved parameters. Thereby, the choice of the prior distribution reflects the level of evidence on the parameters. The expected power is evaluated for a range of scenarios and compared to the classical power for a fixed parameter setting. The new method is illustrated with a clinical trial example.

Keywords: Clinical trial; Composite endpoint; Multiple testing; Non inferiority; Expected power (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167947312003921
Full text for ScienceDirect subscribers only.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:http://EconPapers.repec.org/RePEc:eee:csdana:v:60:y:2013:i:c:p:111-122

Access Statistics for this article

Computational Statistics & Data Analysis is currently edited by S.P. Azen

More articles in Computational Statistics & Data Analysis from  Elsevier
Series data maintained by Dana Niculescu (repec@elsevier.com).

For further details log on website :
http://econpapers.repec.org/article/eeecsdana/v_3a60_3ay_3a2013_3ai_3ac_3ap_3a111-122.htm